Interim analysis of the NAPOLEON-2 study: Safety evaluation of nanoliposomal irinotecan with fluorouracil and folinic acid for unresectable pancreatic cancer patients with prior biliary drainage

被引:0
|
作者
Koga, F. [1 ]
Shirakawa, T. [2 ]
Shimokawa, M. [3 ]
Otsuka, T. [4 ]
Shimokawa, H. [5 ]
Nakazawa, J. [6 ]
Oda, H. [7 ]
Takeshita, S. [8 ]
Kawaguchi, Y. [9 ]
Arita, S. [10 ]
Taguchi, H. [11 ]
Sakai, T. [12 ]
Nishikawa, K. [13 ]
Arima, S. [14 ]
Ueda, Y. [15 ]
Kawahira, M. [16 ]
Sakae, T. [17 ]
Ide, Y. [18 ]
Mizuta, T. [19 ]
Mitsugi, K. [20 ]
机构
[1] Saga Ken Med Ctr Koseikan, Dept Hepatobiliary & Pancreatol, Saga, Japan
[2] Karatsu Higashimatsuura Med Assoc Med Ctr, Internal Med Dept, Saga, Japan
[3] Yamaguchi Univ, Dept Biostat, Grad Sch Med, Ube, Japan
[4] Minato Med Clin, Internal Med, Fukuoka, Japan
[5] JCHO Japan Community Healthcare Org, Kyushu Hosp, Dept Hematol Oncol, Kitakyushu, Fukuoka, Japan
[6] Kagoshima City Hosp, Dept Med Oncol, Kagoshima, Japan
[7] Saiseikai Kumamoto Hosp, Div Integrat Med Oncol, Kumamoto, Japan
[8] Japanese Red Cross, Dept Gastroenterol, Nagasaki Genbaku Hosp, Nagasaki, Japan
[9] Asakura Med Assoc Hosp, Dept Gastroenterol, Asakura, Japan
[10] Miyazaki Prefectural Miyazaki Hosp, Internal Med & Chemotherapy, Miyazaki, Japan
[11] Imamura Gen Hosp, Dept Gastroenterol, Kagoshima, Japan
[12] Natl Hosp Org, Dept Med Oncol, Kumamoto Med Ctr, Kumamoto, Japan
[13] Oita Univ, Dept Med Oncol & Hematol, Fac Med, Yufu, Japan
[14] Kagoshima Univ, Digest & Lifestyle Dis, Kagoshima, Japan
[15] Japanese Red Cross, Dept Hematol & Oncol, Kumamoto Hosp, Kumamoto, Japan
[16] Kagoshima Kouseiren Hosp, Dept Gastroenterol, Kagoshima, Japan
[17] Saiseikai Sendai Hosp, Dept Gastroenterol, Satsumasendai, Japan
[18] Saga Hosp, Natl Hosp Org, Dept Internal Med, Saga, Japan
[19] Fujikawa Hosp, Dept Internal Med, Saga, Japan
[20] Sasebo Kyosai Hosp, Dept Med Oncol, Sasebo, Japan
关键词
D O I
10.1016/j.annonc.2023.10.287
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
152P
引用
收藏
页码:S1534 / S1534
页数:1
相关论文
共 35 条
  • [31] Liposomal irinotecan with fluorouracil and leucovorin after gemcitabine-based therapy in Japanese patients with metastatic pancreatic cancer: additional safety analysis of a randomized phase 2 trial
    Furuse, Junji
    Ueno, Makoto
    Ikeda, Masafumi
    Okusaka, Takuji
    Teng, Zhaoyang
    Furuya, Momoko
    Ioka, Tatsuya
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2023, 53 (02) : 130 - 137
  • [32] Phase 2 randomized study evaluating safety, efficacy, and optimal dose of ABBV-400 in combination with fluorouracil, folinic acid, and bevacizumab in previously treated patients with metastatic colorectal cancer
    Raghav, Kanwal Pratap Singh
    Hubert, Ayala
    Fakih, Marwan
    Fang, Hua
    Aristide, Martha Raluca Neagu
    de Almeida, Carla Biesdorf
    Vasilopoulos, Athanasios
    Sui, Yunxia
    Strickler, John H.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [33] Phase 2 randomized study evaluating safety, efficacy, and optimal dose of ABBV-400 in combination with fluorouracil, folinic acid, and bevacizumab in previously treated patients with metastatic colorectal cancer.
    Raghav, Kanwal Pratap Singh
    Hubert, Ayala
    Fakih, Marwan
    Fang, Hua
    Aristide, Martha Raluca Neagu
    de Almeida, Carla Biesdorf
    Vasilopoulos, Athanasios
    Sui, Yunxia
    Strickler, John H.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : TPS308 - TPS308
  • [34] Efficacy and safety of nanoliposomal irinotecan (nal-IRI, MM-398, PEP02, BAX-2398) in patients with metastatic pancreatic cancer in Asia: A subgroup analysis of the phase 3 NAPOLI-1 Study
    Chen, L-T.
    Li, C-P.
    Chiu, C-F.
    Shan, Y-S.
    Park, J. O.
    Chen, J-S.
    Kim, J. S.
    Rau, K-M.
    de Jong, F.
    Pipas, M.
    Belanger, B.
    Wang, E.
    Lee, K-H.
    Bang, Y-J.
    ANNALS OF ONCOLOGY, 2016, 27
  • [35] Early assessment of safety and efficacy of tropifexor, a potent non bile-acid FXR agonist, in patients with primary biliary cholangitis: An interim analysis of an ongoing phase 2 study
    Schramm, C.
    Hirschfield, G.
    Mason, A. L.
    Wedemeyer, H.
    Klickstein, L.
    Neelakantham, S.
    Koo, P.
    Sanni, J.
    Badman, M.
    Jones, D.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S103 - S103